SCHEMBL6721604

SCHEMBL6721604

O=S(=O)(Cc1ccc(-c2ncccc2-c2ccccc2)cc1F)Cc1ccc(-c2ncccc2-c2ccccc2)cc1F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.51
PTGS1 P23219 1/20 0.51
FEN1 P39748 8/20 0.46
ALOX5AP P20292 6/20 0.39
TOP1 P11387 2/20 0.39
MALT1 Q9UDY8 1/20 0.38
KMO O15229 1/20 0.37
ALDH1A1 P00352 2/20 0.36
HTT P42858 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CTSL P07711 1/20 0.36
PTPRC P08575 1/20 0.36
CTSS P25774 1/20 0.36
PTPN13 Q12923 1/20 0.36
BDKRB1 P46663 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
TDP2 O95551 1/20 0.35
NSD2 O96028 1/20 0.35
ABL1 P00519 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6726098 0.92 PTGS2 (0.42) PTGS2PTGS1FEN1ALOX5APTOP1
SCHEMBL6722643 0.91 PTGS2 (0.41) PTGS2PTGS1FEN1ALOX5APKMO
SCHEMBL6723197 0.90 MALT1 (0.42) PTGS2PTGS1FEN1ALOX5APMALT1
SCHEMBL6730013 0.90 PTGS2 (0.43) PTGS2PTGS1FEN1ALOX5APKMO
SCHEMBL6718600 0.90 GLO1 (0.42) PTGS2PTGS1FEN1ALOX5APTOP1
SCHEMBL6723468 0.89 PTGS2 (0.51) PTGS2PTGS1FEN1ALOX5AP
SCHEMBL6730237 0.89 FEN1 (0.41) PTGS2PTGS1FEN1ALOX5APMALT1
SCHEMBL6722680 0.89 PTGS2 (0.39) PTGS2PTGS1FEN1ALOX5APKMO
SCHEMBL6722946 0.88 TRPV1 (0.43) PTGS2PTGS1TOP1MALT1
SCHEMBL6721827 0.87 PDE3B (0.41) PTGS2PTGS1FEN1ALOX5APKMO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040092552-A1 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2004-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040092552-A1 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation FPR2, PTGES2, FPR1 PTGS2 5/4885PTGS1 4/4885FEN1 1713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.